(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -101.63%-28K | 107.22%131K | 49.78%-1.73M | 54.98%-4.73M | 72.68%-1.19M | 172.57%1.71M | 41.35%-1.81M | -405.65%-3.44M | -650.36%-10.51M | -3,369.05%-4.37M |
Net income from continuing operations | 30.29%-4.76M | -102.14%-9.37M | -108.13%-8.78M | -62.48%-23.64M | -69.16%-7.96M | -41.55%-6.83M | -56.36%-4.63M | -105.18%-4.22M | -351.05%-14.55M | -238.22%-4.71M |
Operating gains losses | -111.67%-343K | 84.62%-193K | 508.18%1.75M | -95.88%99K | -45.53%-1.16M | 13.96%2.94M | -329.01%-1.26M | ---428K | 680.19%2.4M | -1,323.08%-795K |
Depreciation and amortization | 72.07%1.73M | 76.20%1.18M | 129.46%1.4M | 16.96%3.24M | -54.45%957K | 84.59%1.01M | 466.10%668K | 7,659.72%611K | 8,841.94%2.77M | 29,914.29%2.1M |
Asset impairment expenditure | --359K | --3.49M | 128.71%478K | -15.28%2.68M | -21.88%2.47M | --0 | --0 | --209K | --3.17M | --3.17M |
Remuneration paid in stock | ---- | ---- | -89.19%4K | -47.75%186K | ---- | ---- | ---- | --37K | 2,125.00%356K | 1,600.00%187K |
Remuneration paid in stock | -47.81%119K | -22.36%125K | -76.25%180K | -21.04%1.31M | -51.82%159K | 185.00%228K | 5.23%161K | -30.50%758K | 95.97%1.65M | 8,150.00%330K |
Deferred tax | -205.62%-272K | 7.10%-288K | -201.04%-194K | -216.98%-613K | ---406K | -125.43%-89K | -278.16%-310K | --192K | --524K | --0 |
Other non cashItems | 191.53%3.1M | 126.38%2.96M | 173.65%2.98M | 109.96%6.41M | 107.93%2.91M | 102.48%1.06M | 16.06%1.31M | 24,051.70%1.09M | --3.05M | --1.4M |
Change In working capital | -98.88%38K | -0.89%2.23M | 127.26%459K | 156.73%5.61M | 127.23%1.65M | 298.25%3.39M | 196.85%2.25M | -926.30%-1.68M | -832.39%-9.88M | -613.32%-6.05M |
-Change in receivables | -191.97%-756K | 330.38%1.8M | -355.06%-1.75M | 113.82%731K | --1.07M | --822K | 83.11%-780K | -7,360.04%-385K | ---5.29M | ---- |
-Change in inventory | -52.11%1.55M | -112.64%-299K | 154.23%1.69M | 161.40%3.82M | 131.13%1.32M | 341.80%3.25M | 462.88%2.37M | ---3.11M | ---6.22M | ---4.23M |
-Change in payables and accrued expense | -12.93%-760K | 10.29%729K | -70.91%526K | -35.42%1.05M | 75.15%-742K | -149.93%-673K | -77.59%661K | 464.11%1.81M | 17.49%1.63M | -349.67%-2.99M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -101.63%-28K | 107.22%131K | 49.78%-1.73M | 54.98%-4.73M | 72.68%-1.19M | 172.57%1.71M | 41.35%-1.81M | -405.65%-3.44M | -650.36%-10.51M | -3,369.05%-4.37M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 51.93%-299K | 112.79%160K | 92.72%-125K | 91.32%-4.48M | -110.76%-888K | 65.11%-622K | 97.76%-1.25M | 91.70%-1.72M | -3,876.41%-51.57M | 991.47%8.26M |
Net PPE purchase and sale | 84.58%-35K | 87.82%-91K | 93.58%-106K | 41.71%-2.98M | 88.48%-356K | 84.65%-227K | -53.07%-747K | -2,648.20%-1.65M | ---5.12M | ---3.09M |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -7,273.02%-45.64M | --0 |
Net investment purchase and sale | --0 | --400K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other investing changes | 33.16%-264K | 70.44%-149K | 70.77%-19K | -82.66%-1.5M | -104.69%-532K | -29.93%-395K | 94.91%-504K | 99.68%-65K | -20.80%-819K | 3,795.11%11.34M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 51.93%-299K | 112.79%160K | 92.72%-125K | 91.32%-4.48M | -110.76%-888K | 65.11%-622K | 97.76%-1.25M | 91.70%-1.72M | -3,876.41%-51.57M | 991.47%8.26M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -120.98%-103K | -114.68%-258K | -128.75%-516K | -88.41%7.34M | 194.45%3.3M | 1,192.11%491K | -97.38%1.76M | -90.23%1.8M | 1,151.79%63.38M | -429.41%-3.5M |
Net issuance payments of debt | 22.56%-103K | 42.21%-308K | 7.43%-486K | -89.53%1.67M | 158.77%2.07M | -17.70%-133K | -102.65%-533K | ---525K | --15.98M | ---3.52M |
Net common stock issuance | --0 | --0 | ---- | -89.48%2.25M | --0 | --0 | -89.13%2.25M | ---- | 665.71%21.39M | --0 |
Proceeds from stock option exercised by employees | --0 | 25.00%50K | -97.94%50K | 608.02%2.47M | --0 | --0 | 122.22%40K | 1,454.60%2.43M | -85.46%349K | -97.99%24K |
Net other financing activities | ---- | ---- | 27.93%-80K | -96.30%950K | --1.23M | --624K | ---- | -100.61%-111K | 19,686.26%25.66M | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -120.98%-103K | -114.68%-258K | -128.75%-516K | -88.41%7.34M | 194.45%3.3M | 1,192.11%491K | -97.38%1.76M | -90.23%1.8M | 1,151.79%63.38M | -429.41%-3.5M |
Net cash flow | ||||||||||
Beginning cash position | 1.80%737K | -63.79%713K | -38.63%3.12M | 41.87%5.08M | -52.48%2.24M | -91.57%724K | 246.65%1.97M | 41.88%5.08M | 195.21%3.58M | 32.19%4.72M |
Current changes in cash | -127.16%-430K | 102.52%33K | 29.52%-2.37M | -243.42%-1.86M | 213.37%1.22M | 138.54%1.58M | -116.30%-1.31M | -11.55%-3.36M | -45.10%1.3M | 4,222.22%389K |
Effect of exchange rate changes | 103.08%2K | -114.29%-9K | -114.40%-36K | -149.25%-98K | -1,016.13%-346K | -127.43%-65K | 1,000.00%63K | --250K | --199K | ---31K |
End cash Position | -86.22%309K | 1.80%737K | -63.79%713K | -38.63%3.12M | -38.63%3.12M | -52.48%2.24M | -91.57%724K | 246.56%1.97M | 41.87%5.08M | 41.87%5.08M |
Free cash from | -104.24%-63K | 101.56%40K | 64.01%-1.83M | 50.64%-7.71M | 79.22%-1.55M | 138.71%1.49M | 28.48%-2.56M | -587.95%-5.09M | -1,015.79%-15.62M | -5,820.63%-7.46M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data